This esteemed group of institutional investors, industry analysts, and senior biotechnology executives will help shape the 2021 digital program: 

Jennifer Hawks Bland, CEO, NewYorkBIO

Janice Bourque, Managing Director, Life Sciences, Hercules Capital

Aoife Brennan, MB, BCh, BAO, MRCPI, President and CEO, Synlogic

Alexandria Forbes, PhD, President and Chief Executive Officer, MeiraGTx

Andrew Gitkin, Managing Director, Co-Head of Healthcare Investment Banking, Raymond James

Lan Huang, PhD, Co-founder, Chairman & Chief Executive Officer, BeyondSpring

Anna Kazanchyan, MD, Chairwoman and CEO, Saghmos Therapeutics

Ciara Kennedy, PhD, President and CEO, Amplyx

Jonathan Leff, Partner, Deerfield Management

Evan Loh, MD, CEO, Paratek

Sara Nayeem, MD, Partner, New Enterprise Associates

Kimberly Nearing, Venture Partner, BVCF

Susan Peschin, President and CEO, Alliance for Aging Research

Jason Pitts, PhD, Principal, Sofinnova

Dennis Purcell, Founder and Senior Advisor, Aisling Capital

Philip Ross, Vice Chairman, Healthcare Investment Banking, J.P. Morgan

Jennifer Sheng, Managing Director, Healthcare Equity Capital Markets, Citigroup Global Markets